Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296460219> ?p ?o ?g. }
Showing items 1 to 26 of
26
with 100 items per page.
- W4296460219 abstract "Results of the randomized phase 3 IPSOS trial, which specifically focused on patients with non–small cell lung cancer (NSCLC) unfit for platinum-doublet chemotherapy, establishes atezolizumab monotherapy as a new standard of care for these individuals based on a slew of safety and efficacy improvements, most notably in overall survival (OS)." @default.
- W4296460219 created "2022-09-20" @default.
- W4296460219 date "2022-09-19" @default.
- W4296460219 modified "2023-10-18" @default.
- W4296460219 title "First-Line Atezolizumab Doubles 2-Year Survival Versus Single-Agent Chemotherapy in Unfit Patients With Non–Small Cell Lung Cancer" @default.
- W4296460219 doi "https://doi.org/10.1200/adn.22.201118" @default.
- W4296460219 hasPublicationYear "2022" @default.
- W4296460219 type Work @default.
- W4296460219 citedByCount "0" @default.
- W4296460219 crossrefType "dataset" @default.
- W4296460219 hasLocation W42964602191 @default.
- W4296460219 hasOpenAccess W4296460219 @default.
- W4296460219 hasPrimaryLocation W42964602191 @default.
- W4296460219 hasRelatedWork W2045806517 @default.
- W4296460219 hasRelatedWork W2070962078 @default.
- W4296460219 hasRelatedWork W2124411053 @default.
- W4296460219 hasRelatedWork W2402993451 @default.
- W4296460219 hasRelatedWork W2588169328 @default.
- W4296460219 hasRelatedWork W2948845624 @default.
- W4296460219 hasRelatedWork W3043396140 @default.
- W4296460219 hasRelatedWork W3139593660 @default.
- W4296460219 hasRelatedWork W3189911105 @default.
- W4296460219 hasRelatedWork W3215044659 @default.
- W4296460219 isParatext "false" @default.
- W4296460219 isRetracted "false" @default.
- W4296460219 workType "dataset" @default.